Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 6, Pages 1362
Publisher
MDPI AG
Online
2021-03-18
DOI
10.3390/cancers13061362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
- (2020) Meghan A. Morrissey et al. IMMUNITY
- LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression
- (2019) ErQing Chai et al. Cancer Management and Research
- Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue
- (2019) Yu Si et al. Science Immunology
- How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
- (2018) Annika M. Bruger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical relevance and suppressive capacity of human MDSC subsets
- (2018) Stephan Lang et al. CLINICAL CANCER RESEARCH
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms
- (2018) Dmitri Negorev et al. Scientific Reports
- Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
- (2018) Hanke L. Matlung et al. Cell Reports
- Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
- (2017) Xing Li et al. Oncotarget
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Peripheral Blood Neutrophil Granulocytes from Patients with Head and Neck Squamous Cell Carcinoma Functionally Differ from Their Counterparts in Healthy Donors
- (2017) S. Trellakis et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab
- (2016) A. Martens et al. CLINICAL CANCER RESEARCH
- Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
- (2016) Katrin Moses et al. SEMINARS IN IMMUNOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
- (2015) C. Gebhardt et al. CLINICAL CANCER RESEARCH
- Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
- (2015) Jitka Y. Sagiv et al. Cell Reports
- Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
- (2014) Evgeniy B. Eruslanov et al. JOURNAL OF CLINICAL INVESTIGATION
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
- (2013) Kimberly R. Jordan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
- (2013) Janesh Pillay et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Neutrophil Function: From Mechanisms to Disease
- (2012) Borko Amulic et al. Annual Review of Immunology
- A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
- (2011) Janesh Pillay et al. JOURNAL OF CLINICAL INVESTIGATION
- CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function
- (2011) Jahyang Choi et al. TUMOR BIOLOGY
- Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties
- (2010) Sven Brandau et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
- (2009) C. A. Corzo et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation